The number of people with susceptibility test result for rifampicin in Hong Kong
Hong Kong: The number of people with susceptibility test result for rifampicin was 2,181 in 2021. ▼ Falling
Latest (2021)
2,181
Change on year
up 3.6%
World rank
45th
of 155 countries
All-time high
2,533
in 2018
All-time low
2,105
in 2020
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Hong Kong, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
In 2021, the number of people with susceptibility test result for rifampicin in Hong Kong stood at 2,181.
That represents a change of up 3.6% on the previous year and down 4.6% over five years.
That places Hong Kong 45th out of 155 countries with data for 2021, putting it in the middle of the range.
The number of people with susceptibility test result for rifampicin in Hong Kong, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 2,285 | — |
| 2018 | 2,533 | +10.9% |
| 2019 | 2,343 | -7.5% |
| 2020 | 2,105 | -10.2% |
| 2021 | 2,181 | +3.6% |
Hong Kong compared with similar countries
- Hong Kong's 2,181 is above the median for high income countries, which is 142, 15.4× the median. (61 countries reporting)
- Hong Kong's 2,181 is above the median for East Asia & Pacific, which is 185, 11.8× the median. (28 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 2,387 | 2,285 | 2,533 | 3 |
| 2020s | 2,143 | 2,105 | 2,181 | 2 |
Countries ranked near Hong Kong
More health data for Hong Kong
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.0171 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 2,924 deaths per 1,000 people (2090)
- Number of infants who die before age 1 2 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -2.73 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0137 units per person (2025)
- Population ages 00-04, male, annual growth rate -2.11 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Hong Kong?
- The number of people with susceptibility test result for rifampicin in Hong Kong was 2,181 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Hong Kong?
- The highest recorded value was 2,533 in 2018.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Hong Kong?
- The lowest recorded value was 2,105 in 2020.
- How does Hong Kong rank for the number of people with susceptibility test result for rifampicin?
- Hong Kong ranks 45th out of 155 countries with data for 2021.
- Where does this Hong Kong data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).